Mark Identification

OPDUALAG (NIVOLUMAB AND RELATLIMAB-RMBW)

Serial Number

97342302

Filing Date

Apr 1, 2022

Registration Date

Aug 8, 2023

Trademark by

Active Trademark

Classification Information

Pharmaceutical preparations for human use comprising monoclonal antibodies for the treatment and prevention of cancer